Evidence map›Paper›PMID 39578094›Full record

ArticleGlobal health, science and practice2024

Health System Factors Influencing the Integration of Pre-Exposure Prophylaxis into Antenatal and Postnatal Clinic Services in Cape Town, South Africa.

Lara Court, Aurelie Nelson, Reghana Taliep, Sarah Schoetz Dean, Rufaro Mvududu, Lucia Knight, Kathryn Dovel, Thomas Coates, Landon Myer, Dvora L Joseph Davey

Abstract read
In one paragraph

Article in Global health, science and practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lara CourtDivision of Social and Behavioural Sciences, School of Public Health, University of Cape Town, Cape Town, South Africa. lara.court@uct.ac.za.
Aurelie NelsonDivision of Epidemiology and Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa.
Reghana TaliepWestern Cape Department of Health and Wellness, Metro Health Services, Cape Town, South Africa.
Sarah Schoetz DeanDivision of Infectious Diseases, Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Rufaro MvududuDivision of Epidemiology and Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa.
Lucia KnightDivision of Social and Behavioural Sciences, School of Public Health, University of Cape Town, Cape Town, South Africa.
Kathryn DovelDivision of Infectious Diseases, Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Thomas CoatesDivision of Infectious Diseases, Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Landon MyerDivision of Epidemiology and Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa.
Dvora L Joseph DaveyDivision of Epidemiology and Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa.

Funding

Evaluating the PrEP cascade in HIV-negative pregnant and breastfeeding women in South Africa (PrEP-PP)R01MH116771 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JOSEPH DAVEY, DVORA LEAH, MYER, BENJAMIN LANDON · 2018 to 2022
$2.5M
Evaluation of pre-exposure prophylaxis cascade in pregnant and breastfeeding women in Cape Town, South AfricaK01TW011187 · FIC · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JOSEPH DAVEY, DVORA LEAH · 2018 to 2022
$698k
FIC NIH HHS K01 TW011187NIMH NIH HHS R01 MH116771
6 · The paper itself

Abstract

introductionOral pre-exposure prophylaxis (PrEP) is an effective and safe option to prevent HIV acquisition and vertical HIV transmission in pregnant and breastfeeding women. Understanding health system factors influencing the integration of PrEP into care for pregnant and breastfeeding women is key to increasing access. We explored managers' and health care workers' (HCWs) experiences with integrating PrEP into antenatal care and postnatal care services in primary health care clinics in Cape Town, South Africa.

methodsThis exploratory qualitative study used codebook thematic analysis, where HCWs were purposively, heterogeneously sampled from an implementation science study. Semistructured individual interviews were conducted with 9 managerial-level staff, and 3 focus group discussions were conducted with HCWs (nurses, midwives, and HIV counselors) providing PrEP (6-7 HCWs per group) between November 2022 and January 2023 (N=28). Interview guides covered health system facilitators, barriers, and recommendations. The Health Systems Dynamics framework guided data analysis and presentation of results.

resultsPrEP integration into antenatal care services was described as acceptable and feasible; however, changes to HIV testing policy and indicators in breastfeeding women are needed to integrate PrEP into postnatal clinics, together with identification of mother and baby as a dyad in visits. Results showed that supportive policies facilitated wider, simplified PrEP provision. The availability and accessibility of prescribing nurses and lay HIV counselors, PrEP (both within facilities and in communities), and information about PrEP for implementers and pregnant and breastfeeding women will be pivotal to facilitating integration.

conclusionFacilitators for PrEP integration include task-shifting PrEP education and identification of women for PrEP initiation to HIV counselors, changes to national guidelines defining who can prescribe PrEP, revision and integration of PrEP training for HCWs, community-level interventions for PrEP demand creation and stigma reduction, and provision of differentiated PrEP delivery options.

Indexed as

HIV InfectionsInfectious Disease Transmission, VerticalPre-Exposure ProphylaxisPrenatal CareAdultAnti-HIV AgentsBreast FeedingFemaleFocus GroupsHealth PersonnelHumansPostnatal CarePregnancyQualitative ResearchSouth AfricaAnti-HIV Agents

Identifiers

PMID39578094
PMCPMC11666089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.